About the role
Position: Fractional CDO, Small Molecule Parenteral
Reveal Pharmaceuticals in Cambridge, MA seeks a Fractional Chief Development Officer (contract) to lead our Phase 2 lead asset and broader R&D pipeline. This builder role will guide strategy and execute cross-functional development efforts, with 10–20 hours per week initially and potential expansion for the right candidate.
The ideal candidate blends strategic vision with hands-on execution, collaborating across leadership, scientific founders, and external partners while advancing clinical, #J-18808-Ljbffr